Shelly S. Lo

1.9k total citations
37 papers, 591 citations indexed

About

Shelly S. Lo is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Cancer Research. According to data from OpenAlex, Shelly S. Lo has authored 37 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 13 papers in Public Health, Environmental and Occupational Health and 9 papers in Cancer Research. Recurrent topics in Shelly S. Lo's work include Cancer survivorship and care (12 papers), Palliative Care and End-of-Life Issues (10 papers) and Breast Cancer Treatment Studies (7 papers). Shelly S. Lo is often cited by papers focused on Cancer survivorship and care (12 papers), Palliative Care and End-of-Life Issues (10 papers) and Breast Cancer Treatment Studies (7 papers). Shelly S. Lo collaborates with scholars based in United States. Shelly S. Lo's co-authors include Kathy S. Albain, Andrew J. Epstein, Joseph J. Kash, Daniel F. Hayes, John D. Norton, Jeffrey B. Smerage, Patricia Mumby, Karen Rychlik, Ellen R. Gaynor and Helen K. Chew and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Obesity.

In The Last Decade

Shelly S. Lo

32 papers receiving 579 citations

Peers

Countries citing papers authored by Shelly S. Lo

Since Specialization

Citations

This map shows the geographic impact of Shelly S. Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelly S. Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelly S. Lo more than expected).

Fields of papers citing papers by Shelly S. Lo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelly S. Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelly S. Lo. The network helps show where Shelly S. Lo may publish in the future.

Co-authorship network of co-authors of Shelly S. Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Shelly S. Lo. A scholar is included among the top collaborators of Shelly S. Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelly S. Lo. Shelly S. Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti‐aquaporin‐4 immunoglobulin G/anti‐myelin oligodendrocyte glycoprotein immunoglobulin G double‐positive paraneoplastic neurological syndrome in a patient with triple‐negative breast cancer 2023 ·Clinical and Experimental Neuroimmunology ·(unknown), (unknown), (unknown), Vikram C. Prabhu, Shelly S. Lo, Derek A. Wainwright, (unknown), Tamer Refaat, (unknown), Jigisha P. Thakkar	0
2	Discordance of HER2 Positive Classic Invasive Lobular Carcinoma Between IHC/FISH and Oncotype DX: A Case Report and Literature Review 2022 ·Surgical Case Reports ·(unknown), (unknown), Anthony R. Wheeler, Shelly S. Lo, Ping Tang	1
3	Outcomes of Specialty Palliative Care Interventions for Patients With Hematologic Malignancies: A Systematic Review 2021 ·Journal of Pain and Symptom Management ·Elizabeth Elliott, (unknown), (unknown), Hong-Nei Wong, Shelly S. Lo	11
4	Genomic risk classification by the 70-gene signature and 21-gene assay in African American early-stage breast cancer patients. 2021 ·Journal of Clinical Oncology ·Patricia A. Robinson, Michaela L. Tsai, Shelly S. Lo, June Lee, (unknown), Heather M. Kling, (unknown), (unknown), William Audeh	2
5	Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non–Safety-Net Centers 2021 ·JCO Oncology Practice ·Julia R. Trosman, Christine B. Weldon, Bruce D. Rapkin, Al B. Benson, Della Makower, Su‐Ying Liang, Swati Kulkarni, (unknown), Shelly S. Lo, Editha A. Krueger, Alyssa Throckmorton, Christopher Gallagher, Kent Hoskins, (unknown), Jennifer Van Horn, Lidia Schapira, Arliene Ravelo, Elaine Yu, William J. Gradishar	6
6	4R program results: What is the impact of 4R care delivery model on patient self-management and which patients benefited? 2020 ·Journal of Clinical Oncology ·Julia R. Trosman, Christine B. Weldon, Della Makower, Bruce D. Rapkin, (unknown), (unknown), Swati Kulkarni, (unknown), Kent Hoskins, Christopher Gallagher, Shelly S. Lo, (unknown), Alyssa Throckmorton, Editha A. Krueger, Jennifer Van Horn, Arliene Ravelo, Elaine Yu, Lidia Schapira, Al B. Benson, William J. Gradishar	0
7	Palliative Care Opportunities Among Adults With Congenital Heart Disease—A Systematic Review 2019 ·Journal of Pain and Symptom Management ·(unknown), Jill M. Steiner, Hong-Nei Wong, (unknown), Jason Leong, Rebecca A. Aslakson, Katherine Ast, Thomas Carroll, Elizabeth Dzeng, Krista L. Harrison, Erica C. Kaye, Thomas W. LeBlanc, Shelly S. Lo, (unknown), Savithri Nageswaran, James S. Powers, Joseph Rotella, Christina Ullrich, (unknown)	9
8	Introduction to a New Special Series for the Journal of Pain and Symptom Management—Science in Action: Evidence and Opportunities for Palliative Care Across Diverse Populations and Care Settings 2019 ·Journal of Pain and Symptom Management ·Rebecca A. Aslakson, Katherine Ast, Thomas Carroll, Elizabeth Dzeng, Krista L. Harrison, Erica C. Kaye, Thomas W. LeBlanc, Shelly S. Lo, (unknown), Savithri Nageswaran, James S. Powers, Joseph Rotella, Christina Ullrich, (unknown)	1
9	Opportunities to Improve Utilization of Palliative Care Among Adults With Cystic Fibrosis: A Systematic Review 2019 ·Journal of Pain and Symptom Management ·(unknown), Andrea Jonas, (unknown), (unknown), Hong-Nei Wong, Rebecca A. Aslakson, Katherine Ast, Thomas Carroll, Elizabeth Dzeng, Krista L. Harrison, Erica C. Kaye, Thomas W. LeBlanc, Shelly S. Lo, (unknown), Savithri Nageswaran, James S. Powers, Joseph Rotella, Christina Ullrich, (unknown)	2
10	End-of-Life Care, Palliative Care Consultation, and Palliative Care Referral in the Emergency Department: A Systematic Review 2019 ·Journal of Pain and Symptom Management ·Jennifer G. Wilson, Diana P. English, Clark G. Owyang, (unknown), Corita R. Grudzen, Hong-Nei Wong, Rebecca A. Aslakson, Katherine Ast, Thomas Carroll, Elizabeth Dzeng, Krista L. Harrison, Erica C. Kaye, Thomas W. LeBlanc, Shelly S. Lo, (unknown), Savithri Nageswaran, James S. Powers, Joseph Rotella, Christina Ullrich, (unknown)	29
11	Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008) 2018 ·Obesity ·Heather Greenlee, Danika L. Lew, Dawn L. Hershman, Vicky A. Newman, Lisa Hansen, Sheri J. Hartman, Judith Körner, Zaixing Shi, Christine L. Sardo Molmenti, (unknown), L. Fehrenbacher, Shelly S. Lo, Jennifer R. Klemp, Kristine Rinn, John M. Robertson, Joseph M. Unger, Julie R. Gralow, Kathy S. Albain, Robert S. Krouse, Carol J. Fabian	5
12	How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? 2017 ·npj Breast Cancer ·Katherine D. Crew, Kathy S. Albain, Dawn L. Hershman, Joseph M. Unger, Shelly S. Lo	33
13	Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay 2017 ·JAMA Oncology ·Michaela L. Tsai, Shelly S. Lo, William Audeh, Rubina Qamar, (unknown), Ellis Levine, Pat W. Whitworth, Blanche H. Mavromatis, Robin Zoň, (unknown), (unknown), (unknown), (unknown), Hatem Soliman	32
14	The 70-gene signature to provide risk stratification and treatment guidance for patients classified as intermediate by the 21-gene assay. 2016 ·Journal of Clinical Oncology ·Michaela L. Tsai, (unknown), (unknown), Shelly S. Lo, (unknown)	3
15	Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. 2010 ·PubMed ·(unknown), Shelly S. Lo, Kathy S. Albain, Patricia A. Robinson, Prabha Rajan, Peter R. Strack, Todd E. Golde, Lucio Miele, Kimberly E. Foreman	119
16	A Phase II Study of Weekly Docetaxel in Combination with Capecitabine in Advanced Gastric and Gastroesophageal Adenocarcinomas 2010 ·Oncology ·Shelly S. Lo, Alok A. Khorana, Milind Javle, Sheryl R. Simon, (unknown), (unknown), Hong Wang, Alexander Hantel, Michelle Shayne, Jimmy J. Hwang, Amy Schmotzer, Ramesh K. Ramanathan	18
17	Residual Disease After Neoadjuvant Chemotherapy for Breast Cancer 2010 ·Seminars in Oncology ·Gloria J. Morris, Patricia A. Robinson, Shelly S. Lo, Thomas A. Samuel, (unknown), (unknown), Lisa C. Thomas, Krystyna Kiel, Christopher A. Peters	2
18	Neoadjuvant Imatinib in Gastrointestinal Stromal Tumor of the Rectum: Report of a Case 2005 ·Diseases of the Colon & Rectum ·Shelly S. Lo, Georgios I. Papachristou, Sydney Finkelstein, (unknown), Wolfgang H. Schraut, Ramesh K. Ramanathan	43
19	Multimodality Treatment in a Case of Primary Cardiac Lymphoma 2003 ·Clinical Lymphoma ·Shelly S. Lo, Andrew M. Yeager, (unknown), William E. Katz, Ramesh K. Ramanathan	2
20	Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs) 2003 ·Best Practice & Research Clinical Endocrinology & Metabolism ·Shelly S. Lo, Victor G. Vogel	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact